Symbol="KURA"
AssetType="Common Stock"
Name="Kura Oncology Inc"
Description="Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer in the United States. The company is headquartered in San Diego, California."
CIK="1422143"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="792123000"
EBITDA="-147500992"
PERatio="None"
PEGRatio="0"
BookValue="6.2"
DividendPerShare="0"
DividendYield="0"
EPS="-1.97"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.192"
ReturnOnEquityTTM="-0.308"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="29.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.1"
EVToRevenue="-"
EVToEBITDA="-3.404"
Beta="0.764"
num_52WeekHigh="17.27"
num_52WeekLow="9.49"
num_50DayMovingAverage="10.78"
num_200DayMovingAverage="12.3"
SharesOutstanding="74099000"
DividendDate="None"
ExDividendDate="None"
symbol="KURA"
open="10.91"
high="10.91"
low="10.51"
price="10.54"
volume="233520.00"
latest_trading_day="2023-08-22"
previous_close="10.92"
change="-0.38"
change_percent="-3.4799%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="49"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="758887"
Change_recent_avg="-0.04"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="-0.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0049.jpeg"
image_negative_thumbnail_id_2="1102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="620"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_positive_thumbnail_id_2="695"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0013.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
